Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
9793 Daiseki
- 3895
- +10+0.26%
20min DelayNot Open Jan 9 15:30 JST
198.65BMarket Cap20.18P/E (Static)
3960High3865Low132.20KVolume3910Open3885Pre Close515.65MTurnover448552wk High0.35%Turnover Ratio51.00MShares286852wk Low193.8EPS TTM148.97BFloat Cap5670Historical High20.18P/E (Static)38.25MShs Float470Historical Low193.06EPS LYR2.45%Amplitude67.00Dividend TTM2.27P/B100Lot Size1.72%Div YieldTTM
Daiseki Key Stats
Quarterly+Annual
YOY
| (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.41%17.24B | -10.08%16.09B | -6.55%16.7B | 18.17%69.22B | 7.23%15.6B | 14.02%17.85B | 22.39%17.89B | 29.99%17.87B | 3.00%58.57B | 8.20%14.55B |
| Cost of revenue | -2.70%11.37B | -12.69%10.68B | -9.26%10.84B | 19.40%46.54B | 7.49%10.67B | 13.01%11.69B | 25.46%12.23B | 33.39%11.95B | 3.58%38.98B | 9.76%9.93B |
| Gross profit | -4.74%5.87B | -4.45%5.41B | -1.10%5.86B | 15.73%22.68B | 6.66%4.93B | 16.01%6.16B | 16.24%5.66B | 23.63%5.93B | 1.87%19.6B | 4.97%4.62B |
| Operating expense | 5.08%2.07B | 7.75%1.99B | -1.76%1.96B | 14.21%7.86B | 18.59%2.05B | 13.82%1.97B | 4.29%1.85B | 20.67%1.99B | 9.36%6.88B | 11.03%1.73B |
| Staff costs | ---- | ---- | ---- | 7.43%3.94B | ---- | ---- | ---- | ---- | 2.78%3.66B | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | 5.47%810M | ---- | ---- | ---- | ---- | 12.28%768M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 5.47%810M | ---- | ---- | ---- | ---- | 12.28%768M | ---- |
| Research and development costs | ---- | ---- | ---- | 45.25%260M | ---- | ---- | ---- | ---- | 62.73%179M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 5.61%113M | ---- | ---- | ---- | ---- | 5.94%107M | ---- |
| -Depreciation | ---- | ---- | ---- | 5.61%113M | ---- | ---- | ---- | ---- | 5.94%107M | ---- |
| Rent and land expenses | ---- | ---- | ---- | 23.08%240M | ---- | ---- | ---- | ---- | 4.28%195M | ---- |
| Other operating expenses | ---- | ---- | ---- | 27.02%2.5B | ---- | ---- | ---- | ---- | 19.62%1.97B | ---- |
| Operating profit | -9.35%3.8B | -10.35%3.42B | -0.76%3.91B | 16.55%14.82B | -0.48%2.88B | 17.07%4.19B | 23.05%3.82B | 25.19%3.94B | -1.78%12.72B | 1.65%2.89B |
| Net non-operating interest income (expenses) | 7.14%15M | -16.67%10M | -33.33%10M | -5.36%53M | -14.29%12M | 7.69%14M | -29.41%12M | 25.00%15M | 5.66%56M | 27.27%14M |
| Non-operating interest income | 22.22%22M | 5.56%19M | -5.56%17M | 16.39%71M | 13.33%17M | 20.00%18M | 0.00%18M | 38.46%18M | 5.17%61M | 15.38%15M |
| Non-operating interest expense | 75.00%7M | 50.00%9M | 133.33%7M | 260.00%18M | 400.00%5M | 100.00%4M | 500.00%6M | 200.00%3M | 0.00%5M | -50.00%1M |
| Net investment income | 0 | -42.31%30M | -57.14%12M | 0 | 188.89%52M | 300.00%28M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -63.41%15M | -37.50%15M | 41M | 24M | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -98.63%1M | -500.00%-8M | -308.33%-25M | -259.48%-185M | -2,620.00%-272M | 3,750.00%73M | -84.62%2M | -89.57%12M | 451.52%116M | -100.00%-10M |
| Less:Other special charges | 98.63%-1M | 500.00%8M | 256.25%25M | 256.03%181M | 2,620.00%272M | -3,750.00%-73M | 84.62%-2M | 86.09%-16M | -873.33%-116M | 100.00%10M |
| Less:Write off | --0 | --0 | --0 | --4M | --0 | --0 | --0 | --4M | --0 | --0 |
| Other non-operating income (expenses) | 154.90%28M | 131.58%44M | 231.87%302M | 1,330.30%472M | 1,629.63%413M | -51M | -65.45%19M | 1,720.00%91M | -41.07%33M | -370.00%-27M |
| Income before tax | -9.09%3.84B | -9.95%3.49B | 3.50%4.19B | 16.83%15.2B | 4.77%3.05B | 16.97%4.23B | 20.78%3.87B | 23.54%4.05B | -0.20%13.01B | 1.78%2.91B |
| Income tax | -7.61%1.23B | -9.42%1.11B | 0.31%1.31B | 22.86%4.68B | 13.42%828M | 17.83%1.33B | 25.49%1.22B | 33.06%1.3B | -2.11%3.81B | -6.17%730M |
| Net income | -9.70%2.62B | -10.23%2.38B | 5.02%2.89B | 14.34%10.52B | 1.92%2.23B | 16.49%2.9B | 18.78%2.65B | 19.48%2.75B | 0.60%9.2B | 4.70%2.18B |
| Net income continuous operations | -9.77%2.61B | -10.19%2.38B | 5.02%2.89B | 14.34%10.52B | 1.88%2.23B | 16.58%2.9B | 18.73%2.65B | 19.48%2.75B | 0.61%9.2B | 4.75%2.18B |
| Noncontrolling interests | -25.81%207M | -38.54%185M | -37.34%198M | 97.75%1.05B | -3.66%158M | 64.12%279M | 166.37%301M | 267.44%316M | -30.60%533M | 40.17%164M |
| Net income attributable to the company | -7.99%2.41B | -6.64%2.19B | 10.53%2.69B | 9.22%9.47B | 2.38%2.07B | 13.00%2.62B | 10.95%2.35B | 9.85%2.43B | 3.46%8.67B | 2.64%2.02B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -7.99%2.41B | -6.64%2.19B | 10.53%2.69B | 9.22%9.47B | 2.38%2.07B | 13.00%2.62B | 10.95%2.35B | 9.85%2.43B | 3.46%8.67B | 2.64%2.02B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -6.32%50.12 | -4.45%45.73 | 12.68%55.55 | 10.82%193.06 | 3.64%42.4 | 14.39%53.5 | 12.48%47.86 | 12.10%49.3 | 6.21%174.21 | 5.09%40.91 |
| Diluted earnings per share | -6.32%50.12 | -4.50%45.7054 | 12.68%55.55 | 10.82%193.06 | 3.63%42.3709 | 14.39%53.5 | 12.48%47.86 | 12.10%49.3 | 6.21%174.21 | 5.12%40.8883 |
| Dividend per share | 0 | 10.00%33 | 0 | 6.67%64 | 13.33%34 | 0 | 0.00%30 | 0 | 8.43%60 | -6.25%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |